Thus, the aim of our work was to investigate the lipophilic purine nucleosides as the Tdp1 inhibitors and to research whether the leader compounds can sensitize tumor cells in vitro and in vivo to Tpc. The gene discussed is TDP1; the disease is neoplasm.